Medical Journals

Mek Inhibition Exacerbates Ischemic Calcium Imbalance and Neuronal Cell Death in Rat Cortical Cultures.

Authors:
  • Franceschini Davide
  • Giusti Pietro
  • Skaper Stephen D

From: Neurology and GI Centre of Excellence for Drug Discovery, GlaxoSmithKline Research and Development Limited, New Frontiers Science Park, Third Avenue, Harlow CM19 5AW, UK. davide.franceschini@unipd.it

European journal of pharmacology

  • Publish Date: Dec 2006
  • ISSN: 0014-2999
  • Volume: 553
  • Issue: 1-3
  • Pages: 18-27
  • Medium: Print
  • Language: English
  • Citation (JAMA): Franceschini Davide, Giusti Pietro, Skaper Stephen D, et al. Mek Inhibition Exacerbates Ischemic Calcium Imbalance and Neuronal Cell Death in Rat Cortical Cultures.. Eur. J. Pharmacol. Dec 2006;553:18-27

Abstract

Interruption in the brain’s blood supply leads to an ischemic condition, which is characterised by a depletion of energy phosphates and related failure of ionic pumps, increased extracellular potassium, neuronal depolarisation and release of excitatory amino acids, e.g. glutamate. The subsequent activation of N-methyl-d-aspartate glutamate receptors triggers a wide range of intracellular signals, including the mitogen-activated protein kinase (MAPK) pathway. Activation and inhibition of the MAPK/extracellular regulated kinases (ERK) pathway are both reported to be neuroprotective in conditions associated with excitotoxic injury. The present study was designed to explore the involvement of this signalling pathway in cultured rat cortical neurons subjected to chemically-induced ischemia obtained by coupling the mitochondrial toxin 3-nitropropionic acid with glucose deprivation. Loss of neuronal viability, reduced neuronal energy state (ATP level and mitochondrial membrane potential) and increased cytoplasmic mitochondrial calcium were all observed. The NMDA antagonist MK-801 counteracted these effects, suggesting a glutamate-dependent ischemic cell death. Addition of U0126, a selective inhibitor of MAPK kinase, exacerbated this neuronal cell death. However, non-significant changes in activated cAMP response element-binding protein were seen. The rise in cytoplasmic calcium under ischemic conditions was associated with neuronal cell swelling. Both swelling and increase in cytoplasmic calcium were exacerbated and prevented by U0126 and MK-801, respectively. These data suggest that in this ischemic model the MAPK/ERK pathway might exert a regulatory effect on calcium entry independent from gene expression.

Mesh Headings (Keywords): Adenosine Triphosphate, Animals, Blotting, Western, Brain Ischemia, Calcium, Cell Death, Cell Survival, Cells, Cultured, Cerebral Cortex, Cyclic AMP Response Element-Binding Protein, Electron Transport, Energy Metabolism, Extracellular Signal-Regulated MAP Kinases, Female, Glucose, L-Lactate Dehydrogenase, Membrane Potentials, Mitochondrial Membranes, Neurons, Phosphorylation, Pregnancy, Rats, Receptors, Glutamate, Receptors, N-Methyl-D-Aspartate


Check for Full Text / PubMed Unique Identifier (PMID): 17097633


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.